Resistance to antituberculosis drugs in Japan

被引:27
作者
Hirano, K
Kazumi, Y
Abe, C
Mori, T
Aoki, M
Aoyagi, T
机构
[1] Tuberculosis Research Committee, Ryohken
[2] Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association, Kiyose-shi
来源
TUBERCLE AND LUNG DISEASE | 1996年 / 77卷 / 02期
关键词
D O I
10.1016/S0962-8479(96)90027-1
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Setting: Five years after the last survey of drug-resistant tuberculosis in Japan, a serious new phenomenon has gradually begun to appear. A nationwide survey was conducted by the Tuberculosis Research Committee. Objective: To determine resistance patterns to five anti-tuberculosis drugs and risk factors. Design: Cultures were obtained from patients hospitalized at 38 hospitals in various districts of Japan throughout 6 months, from 1 June through 30 November in 1992. Drug susceptibility testing was carried out in the national reference laboratory. Results and Conclusion: Resistance to one or more drugs was found in 5.6% of new cases and 27.8% of recurrent cases (P < 0.001). About 88% of drug resistant isolates from the new cases were resistant to one drug, while 50.8% of the drug resistant isolates from the recurrent cases had resistance to two or more drugs (P < 0.001). Resistance rates to both isoniazid and rifampin in new cases was very low (only 0.14%). Primary drug resistance rates were higher in age groups less than 60 years old, compared to those of 60 years and over (P = 0.05). Compared with the rate in Japanese patients, foreign-born individuals had a higher resistance rate in the recurrent cases (P = 0.034). This survey indicated a similar trend in resistance rates to five antituberculosis drugs to those of the last survey in 1987.
引用
收藏
页码:130 / 135
页数:6
相关论文
共 17 条
[1]   TUBERCULOSIS IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION [J].
BARNES, PF ;
BLOCH, AB ;
DAVIDSON, PT ;
SNIDER, DE .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (23) :1644-1650
[2]   NATIONWIDE SURVEY OF DRUG-RESISTANT TUBERCULOSIS IN THE UNITED-STATES [J].
BLOCH, AB ;
CAUTHEN, GM ;
ONORATO, IM ;
DANSBURY, KG ;
KELLY, GD ;
DRIVER, CR ;
SNIDER, DE .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (09) :665-671
[3]   RESURGENT TUBERCULOSIS IN NEW-YORK-CITY - HUMAN-IMMUNODEFICIENCY-VIRUS, HOMELESSNESS, AND THE DECLINE OF TUBERCULOSIS-CONTROL PROGRAMS [J].
BRUDNEY, K ;
DOBKIN, J .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1991, 144 (04) :745-749
[4]   AN OUTBREAK OF MULTIDRUG-RESISTANT TUBERCULOSIS AMONG HOSPITALIZED-PATIENTS WITH THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME [J].
EDLIN, BR ;
TOKARS, JI ;
GRIECO, MH ;
CRAWFORD, JT ;
WILLIAMS, J ;
SORDILLO, EM ;
ONG, KR ;
KILBURN, JO ;
DOOLEY, SW ;
CASTRO, KG ;
JARVIS, WR ;
HOLMBERG, SD .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (23) :1514-1521
[5]  
GANGADHARAM PRJ, 1984, DRUG RESISTANCE MYCO, P7
[6]   DRUG-RESISTANCE OF MYCOBACTERIUM-TUBERCULOSIS IN KOREA [J].
KIM, SJ ;
HONG, YP .
TUBERCLE AND LUNG DISEASE, 1992, 73 (04) :219-224
[7]   NOSOCOMIAL TRANSMISSION OF MULTIDRUG-RESISTANT MYCOBACTERIUM-TUBERCULOSIS - A RISK TO PATIENTS AND HEALTH-CARE WORKERS [J].
PEARSON, ML ;
JEREB, JA ;
FRIEDEN, TR ;
CRAWFORD, JT ;
DAVIS, BJ ;
DOOLEY, SW ;
JARVIS, WR .
ANNALS OF INTERNAL MEDICINE, 1992, 117 (03) :191-196
[8]   EPIDEMIOLOGY OF TUBERCULOSIS IN THE UNITED-STATES [J].
RIEDER, HL ;
CAUTHEN, GM ;
COMSTOCK, GW ;
SNIDER, DE .
EPIDEMIOLOGIC REVIEWS, 1989, 11 :79-98
[9]  
1990, MMWR-MORBID MORTAL W, V39, P1
[10]  
1991, KEKKAKU, V66, P367